6-TARGET-STEPS
TO TAKE CONTROL OF THE SIDE EFFECTS

THE 6-STEP TARGET METHOD IS A STEP-BY-STEP GUIDE
TO MASTER SIDE EFFECTS EFFECTIVELY & BECOME SUCCESSFUL
TO AVOID UNNECESSARY TREATMENT ADJUSTMENTS.

Where do you start?

HOW IT WORKS

You can walk through the entire process yourself, from labeling the side effects to treating them.

This way, you can control most side effects, especially when approached at an early stage without prescription drugs.

The 6-TARGET Step Adverse Event Blueprint

THE 6 PRACTICAL STEPS:

Step 1: Term: Institute adverse event subtypes.

Step 2: Assess: Assessing the signs and symptoms of an adverse event and its impact on a particular patient is crucial to identifying the intervention direction.

Step 3: Report: Reporting of characteristics of the adverse event subtype tells in detail where to look for an appropriate intervention.

Step 4: Grade: Much better grading tools are available than the CTCAE, which will guide you to the best treatment option for a particular adverse event subtype.

Step 5: Evaluate: If you are on the right path with your measures or if you are approaching the wrong target will become clear in the 5th step.

Step 5: Treat: After applying the previous steps, tackling adverse events becomes the easiest step in adverse event management.

Dr. Christine Boers-Doets, the Side Effects Doctor

Why you need a fire extinguisher to be able to manage side effects from immuno-oncology an targeted therapy effectively

The Fire Extinguisher

Let me ask you something:

Why do you need a fire extinguisher to be able to manage side effects effectively?

Because you need it for the HHES approach.

The HHES approach is part of step 6.

It is not a real fire extinguisher, of course, but something that has the same mode of action.

WHERE DO YOU START?

Ferdinand Haslbauer, MD Oncology, Salzkammergut Klinikum Vöcklabruck, Austria

CHRISTINE´S HHES METHOD (HIT HARD, EARLY & SHORT) EMPHASIZES THE CORRECT DOSING OF DIFFERENT CORTICOSTEROIDS, THEIR EQUIVALENCE DOSAGES, THEIR ANTI-INFLAMMATORY PROPERTIES, AND THE NECESSARY DURATION OF TREATMENT.

A REAL EYE OPENER!

DR. HASLBAUER, MD

MEDICAL ONCOLOGIST, AUSTRIA